NCT05605119 - First in Human, Dose Escalation, Dose Expansion Study of AUR105 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2022

Primary Completion Date

December 30, 2025

Study Completion Date

May 30, 2026

Conditions

Solid Tumor, AdultNon-hodgkin LymphomaHodgkin Lymphoma

Interventions

DRUG

AUR105

Once daily

Trial Locations (9)

RECRUITING

ALL India Institute of medical Scieneces, New Delhi

RECRUITING

Kailash Cancer Hospital and Research Centre, Vadodara

RECRUITING

Moraya Multi-Speciality Hospital, Pune

RECRUITING

Krupamayi Hospital, Aurangabad

RECRUITING

HCG City Cancer Center, Vijayawada

RECRUITING

Omega Hospitals, Visakhapatnam

RECRUITING

IMS&SUM Hospital, Bhubaneswar

RECRUITING

Sparsh Hospital and Critical Care, Bhubaneswar

RECRUITING

All India Institute of Medical Sciences, Bhubaneswar